Litecoin vs Enzyme — how do they compare? Litecoin trades at Rp812,906 (market cap Rp62,78T, Rp5,51T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Litecoin is far larger — about 468053.4× Enzyme's market cap, and Litecoin's supply is capped (77,4M / 84M LTC (93%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Litecoin for 75 Days and Enzyme for 28 Days on average.
| LTC | MLN | |
|---|---|---|
Market Cap | Rp62,78T | Rp134,13M |
Volume (24h) | Rp5,51T | Rp104,56M |
Circulating Supply | 77,4M / 84M LTC (93%) | 3,3M MLN |
Typical Hold Time | 75 Days | 28 Days |
Signals from Pluang's Aura AI — not financial advice
Litecoin is trading at Rp812,906 with a market cap of Rp62.78T, showing bullish technical signals from moving averages while oscillators remain neutral. The asset is positioned above its pivot point of Rp810,477 with immediate resistance at Rp836,660. With 93% of the maximum 84 million LTC supply in circulation and an average hold time of 75 days, the network demonstrates mature token distribution. Recent trading activity shows strong momentum as Litecoin maintains its position as a leading cryptocurrency for fast, low-cost transactions.
Overall outlook remains cautiously optimistic with Litecoin benefiting from its established network effects and reliable transaction capabilities. Key opportunities include continued adoption for cross-border payments and merchant acceptance. Major risks include cryptocurrency market volatility, regulatory uncertainty, and competition from newer blockchain projects. Investors should monitor trading volume patterns and network activity metrics for signs of sustained adoption.
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Litecoin was launched in late 2011 by former Google and Coinbase engineer, Charlie Lee. It was designed to provide fast, secure and low-cost payments by leveraging the unique properties of blockchain technology. It also has a maximum supply of 84 million litecoins.
Read more on LTC →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →